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G protein-coupled receptors (GPCRs) activate four families of
heterotrimeric G proteins, and individual receptors must select a
subset of G proteins to produce appropriate cellular responses.
Although the precise mechanisms of coupling selectivity are
uncertain, the Gα subunit C terminus is widely believed to be
the primary determinant recognized by cognate receptors. Here,
we directly assess coupling between 14 representative GPCRs and
16 Gα subunits, including one wild-type Gα subunit from each of
the four families and 12 chimeras with exchanged C termini. We
use a sensitive bioluminescence resonance energy transfer (BRET)
assay that provides control over both ligand and nucleotide bind-
ing, and allows direct comparison across G protein families. We
find that the Gs- and Gq-coupled receptors we studied are rela-
tively promiscuous and always couple to some extent to Gi1 het-
erotrimers. In contrast, Gi-coupled receptors are more selective.
Our results with Gα subunit chimeras show that the Gα C terminus
is important for coupling selectivity, but no more so than the Gα
subunit core. The relative importance of the Gα subunit core and C
terminus is highly variable and, for some receptors, the Gα core is
more important for selective coupling than the C terminus. Our results
suggest general rules for GPCR-G protein coupling and demonstrate
that the critical G protein determinants of selectivity vary widely, even
for different receptors that couple to the same G protein.
GPCR | G protein-coupled receptor | G protein selectivity | ternary complex
Gprotein coupled receptors (GPCRs) exert many of theirphysiological effects by coupling to and activating hetero-
trimeric G proteins. The 16 human Gα subunit genes are classified
into four families (Gs, Gi/o, Gq/11, and G12/13), and members of each
family interact with different effector molecules to produce distinct
cellular responses (1, 2). Individual cells generally express many
different G proteins from multiple families, and, therefore, GPCRs
must be able to selectively activate subsets of G proteins. Many
receptors show a preference for G proteins from just one of the
four families, although promiscuous coupling to G proteins from
multiple families is also not uncommon (3, 4). The mechanisms of
selective GPCR-G protein coupling are not completely understood,
and the structural determinants of selectivity have not been de-
termined with precision. Analysis of GPCR primary sequences has
not revealed simple conserved motifs for coupling to different G
protein families (5), and analysis of GPCR–G protein complex
structures has only begun to uncover features that may be impor-
tant for coupling selectivity (6–12). From the standpoint of the G
protein, it has long been appreciated that the Gα carboxy (C)
terminus is critical for activation by receptors and also a key de-
terminant of selectivity (13–17). The distal part of the C-terminal
alpha helix (helix 5; H5) is enveloped by GPCR transmembrane
(TM) domains during coupling (6), and several studies have shown
that mutations within this region can promote coupling of receptors
to noncognate heterotrimers (17–21). Although other Gα regions
have been shown to be important for recognition by individual
GPCRs (22–25), the Gα C terminus is widely considered to be the
most important structural determinant of coupling selectivity.
Here, we test this idea by measuring coupling of GPCRs to
four representative Gα subunits (Gαs, Gαi1, Gαq, and Gα12) and
12 Gα chimeras with the C terminus of one representative and
the Gα core region of another. We monitor coupling using a
sensitive energy transfer assay that allows comparison of all
GPCR–G protein combinations directly at the coupling step.
Our results demonstrate unexpectedly promiscuous coupling of
many GPCRs to wild-type G proteins and support the notion
that the Gα C terminus is one important determinant of coupling
selectivity for many receptors. However, our results also show
that the Gα C terminus is a minor contributor to selective cou-
pling of several other receptors. Taken together our findings
suggest that GPCRs recognize widely distributed structural fea-
tures of G proteins and are consistent with the suggestion that
different GPCRs recognize different conserved selectivity de-
terminants of a given G protein (5).
Results
Promiscuous Coupling to Wild-Type G Proteins.Coupling of a GPCR
to a heterotrimeric G protein can be defined as the allosteric
interaction between the ligand binding site of the receptor and
the nucleotide binding site of the associated Gα subunit, such
that the agonist-bound state of the receptor promotes the
nucleotide-free (empty) state of the G protein and vice versa (26,
27) (Fig. 1A). To quantify coupling we monitored agonist-
dependent and nucleotide-sensitive association of GPCRs with
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different heterotrimers using bioluminescence resonance energy
transfer (BRET) (28). To interfere as little as possible with
receptor–G protein interactions, we positioned BRET donor and
acceptor labels far from regions identified in functional and
structural studies as important for coupling. A luciferase was
fused to the GPCR C terminus, and complementary fragments of
the fluorescent protein Venus were fused to Gβ1 and Gγ2 sub-
units. These components were transfected together with un-
labeled Gα subunits into CRISPR/Cas9-edited HEK293 cells
deficient in either Gαs, Gαq, and Gα12 subunit families (three-
family knockouts; 3GKO) or all four Gα families (four-family
knockouts; 4GKO) (29). When 3GKO cells were used, the S1
subunit of pertussis toxin (PTX) was coexpressed to prevent
coupling to endogenous Gαi/o subunits, except when the over-
expressed Gα subunit was itself sensitive to PTX. Cells were
permeabilized with digitonin and either supplemented with GDP
or treated with apyrase to remove residual nucleotides.
Complexes between agonist-bound GPCRs and G proteins are
short-lived when guanine nucleotides are present at concentra-
tions similar to those found in the cytosol of intact cells and are
greatly stabilized when guanine nucleotides are absent (30).
Accordingly, nucleotide depletion significantly enhanced the
magnitude of agonist-induced BRET between receptors and G
proteins (Fig. 1B), and maximal BRET was observed when ag-
onist was present and GDP was absent (Fig. 1C). As a simple
index of coupling, we defined ΔBRETmax as the difference be-
tween the BRET observed when receptor–G protein complexes
are least stable (agonist absent, GDP present) and that observed
when receptor–G protein complexes are most stable (agonist
present, GDP absent). This experimental system allows direct
comparison of receptor coupling to heterotrimers with Gα sub-
units from different families and is sufficiently sensitive to detect
secondary coupling to nonpreferred G proteins. Using this assay,
we found that receptors generally coupled to the same G pro-
teins as indicated by other methods and as annotated in the
IUPHAR/BPS Guide to Pharmacology (3, 31). However, many
receptors coupled to wild-type G proteins more promiscuously
than expected. For example, we found that H1 histamine re-
ceptors (H1R), which are generally classified as Gq-coupled (3),
couple strongly to both Gq and Gi heterotrimers, couple weakly
to Gs heterotrimers, and do not couple significantly to G12 het-
erotrimers (Fig. 1D). The EC50 values for H1R coupling to Gq
and Gi were comparable (Fig. 1E), suggesting that activation of
Gi heterotrimers by this receptor may have physiological signif-
icance, as some studies have indicated (32). We carried out
similar experiments on a panel of 19 receptors (SI Appendix,
Table S1), 17 of which are classified in the IUPHAR/BPS Guide
to Pharmacology (3) as coupling primarily to Gs, Gi, or Gq
proteins, and two of which are unclassified orphan receptors that
transduce signals through G12/13 proteins (33, 34). We found that
promiscuous coupling to more than one wild-type G protein was
a universal feature of the Gs-, Gq- and G12-coupled receptors
that we studied. In contrast, the Gi-coupled receptors that we
studied were much more selective for Gi heterotrimers (Fig. 2
and SI Appendix, Fig. S1). From the perspective of the G protein,
we found that Gi heterotrimers coupled to all of the receptors
that we studied. It should be noted that the assay we used for
these studies reflects allosteric coupling between agonist and
nucleotide binding sites, but this is only a minimum requirement
for agonist-dependent G protein signaling. Additional factors
may be required for efficient G protein activation and signaling
under physiological conditions in cells (see below).
Coupling to G Protein C-Terminal Chimeras. To assess the importance
of the Gα C terminus for coupling selectivity, we constructed 12 Gα
chimeras consisting of the main Gα subunit core [HN.1-H5.16 using
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Fig. 1. Coupling to wild-type heterotrimers in permeabilized, nucleotide-
depleted cells. (A) Receptors were fused to Renilla luciferase (Rluc8), and Gβγ
dimers were fused to Venus. (B) Time course of BRET between H1R-Rluc8 and
Gαi1βγ-Venus in response to 100 μM histamine (HA) in permeabilized cells in
the presence (GDP) and absence (apyrase) of nucleotides. (C and D) H1R
couples to Gs, Gi1, and Gq heterotrimers; **P = 0.0011, ****P < 0.0001, n.s.
not significant; one-way ANOVA, Sidak’s multiple comparisons. Pertussis
toxin S1 subunit (PTX) was coexpressed in experiments with Gαs, Gαq, and
Gα12. (E) Similar potency of histamine-induced coupling to Gi1 (EC50 =
258 nM; n = 4) and Gq (EC50 = 245 nM; n = 7) heterotrimers.
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Fig. 2. Gi-coupled receptors are relatively selective. Normalized ΔBRETmax
for a panel of Gs-, Gi-, Gq-, and G12-coupled receptors. Each value represents
the mean ΔBRETmax (normalized to the value obtained using the presumed
cognate G protein) from n = 3–6 independent experiments. Individual data
points for each receptor are shown in SI Appendix, Fig. S1.
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the common G protein numbering (CGN) system] of Gαs (long
isoform), Gαi1, Gαq, or Gα12 and the final 10 amino acids (H5.17–
26) of each of the others. This portion of the Gα C terminus is
deeply embedded in the TM domains of GPCRs in all receptor–G
protein complex structures and has been called the interface
module of the C-terminal alpha helix (helix 5 or H5) (35). Previous
mutagenesis studies have primarily targeted residues within this
region to alter coupling selectivity (36). This region is also un-
structured in G protein crystal structures (35), suggesting that it is
not involved in folding or stability of the Gα subunit core and,
therefore, can be exchanged without compromising the structural
integrity of heterotrimers. We confirmed the ability of Gα chimeras
to form heterotrimers by monitoring sequestration of overexpressed
Gβγ dimers (37), and all expressed at comparable levels as in-
dicated by immunoprecipitation (SI Appendix, Fig. S2). Conditions
were optimized to provide roughly equivalent stoichiometry for
each receptor–G protein pair, with the latter in excess. For sim-
plicity, we refer to heterotrimers that incorporate these chimeras as
Gsi, Gsq, Gs12. We generated full coupling profiles (4 wild-type Gα
subunits and 12 chimeras) for 14 GPCRs and plotted the results as
ΔBRETmax heat maps (Fig. 3). Similar heat maps were constructed
for GDP-sensitive BRET in the absence of agonist (ΔBRETGDP; SI
Appendix, Fig. S3) and agonist-induced BRET in the presence of
GDP (ΔBRETag; SI Appendix, Fig. S4).
In agreement with our results using wild-type Gα subunits, we
found that Gs-, Gq- and G12-coupled receptors coupled more
promiscuously to G protein chimeras than Gi-coupled receptors.
The Gs-, Gq- and G12-coupled receptors that we studied always
coupled well to several chimeras in addition to wild-type G
proteins, sometimes with ΔBRETmax values that approached or
even exceeded that of the cognate wild-type G protein (Fig. 3).
The Gi-coupled receptors that we studied were more selective.
For example, the D2 dopamine receptor (D2R) failed to couple
to any Gα chimera with a ΔBRETmax value that reached half of
that observed with wild-type Gαi1. We also observed that the
Gα12 core was often nonpermissive for coupling, particularly for
Gi- and Gq-coupled receptors. This was sometimes partially
overcome when a cognate C terminus was present, e.g., for A1R
and H1R. By comparison, the Gα12 C terminus was more ac-
commodating to most receptors (Fig. 3). This suggests that many
receptors reject Gα12 core regions rather than the C terminus to
select against G12 heterotrimers. The most promiscuous receptor
that we studied was the endothelin A (ETAR) receptor, which
coupled well to Gαi1, Gαq, Gα12, and eight of the nine chimeras
bearing the C termini of these subunits. This receptor coupled
poorly to Gαs and chimeras bearing the Gαs C terminus, sug-
gesting that selection against Gs coupling for this receptor is
determined primarily by the C terminus.
We anticipated that GPCRs would couple poorly to chimeras
bearing noncognate C termini, i.e., adding a noncognate C ter-
minus to a cognate Gα core would impair coupling. Indeed, this
was observed for all 42 receptor-chimera pairs that we studied.
However, the extent of impairment was highly variable, ranging
from a near complete loss of coupling to almost no loss (SI
Appendix, Fig. S5A). Gi-coupled receptors, in particular the M4
acetylcholine receptor (M4R) and D2R, were the most sensitive
to noncognate C termini. Conversely, we expected that GPCRs
would generally couple well to chimeras bearing cognate C ter-
mini, i.e., noncognate Gα core regions would only modestly
impair coupling. However, we found that a noncognate Gα core
was often as detrimental to coupling as a noncognate C terminus
(SI Appendix, Fig. S5B). Although adding a cognate C terminus
to a noncognate Gα core usually enhanced coupling, the gain of
coupling was again highly variable and rarely a complete
“switch.” For most of the receptors that we studied, coupling
selectivity was determined both by the Gα subunit core and the C
terminus. A clear C terminus-dominant coupling pattern was
observed for only a few receptors, the most obvious examples
being H1R, P2RY10, and GPR35 (Fig. 3). Other receptors, such
as H2R and A1R, showed a more balanced influence of the
cognate C terminus and G protein core. These receptors coupled
equally well to chimeras bearing either the cognate C terminus
or the cognate G protein core, although coupling to these chi-
meras was never as efficient as coupling to cognate wild-type G
proteins. Unexpectedly, D1R and M3R showed coupling that was
determined almost entirely by the G protein core and was vir-
tually insensitive to the Gα C terminus (Fig. 3). Full concentra-
tion–response curves for these receptors confirmed the patterns
observed with single saturating concentrations of agonists. Spe-
cifically, for the D1R and M3R agonist potency was greater for
chimeras with cognate G protein cores, whereas for the H1R
agonist potency was greater for chimeras with cognate C termini
(SI Appendix, Fig. S6 and Table S2).
Efficient coupling to G proteins with noncognate Gα C ter-
mini was unexpected, and suggested either that the C terminus
contributes little to the stability of some receptor–G protein
complexes or, alternatively, that some receptors can interact
strongly with both cognate and noncognate C termini. To better
understand the basis of efficient coupling to Gα subunits with
noncognate C termini, we performed atomistic molecular dy-
namics (MD) simulations of D1R complexes with Gs, Gsi, Gsq,
and Gs12. These simulations revealed that in all cases, the C
terminus contributed a substantial portion (at least one-third) of
the total Gs protein interaction energy with D1R (SI Appendix,
Fig. S7B) and, therefore, was critical for the overall stability of
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Fig. 3. Coupling to heterotrimers with C-terminal Gα subunit chimeras.
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the complex. However, this receptor accommodated noncognate
C termini with small energetic penalties (SI Appendix, Fig. S7),
which corresponds to the observation that the C terminus was
not critical for D1R selectivity. These simulations also identified
several regions of the Gαs core that contribute to the interaction
and may also contribute to coupling selectivity for this receptor,
including HN, the hns1, s2s3, and h4s6 linkers and N-terminal
residues of H5 (SI Appendix, Fig. S7A).
We then asked if receptors that interacted well with
nucleotide-free G proteins bearing noncognate Gα C termini in
our direct BRET coupling assay and MD simulations could also
efficiently activate these G proteins and produce downstream
signals. We found that wild-type Gs, Gsi, Gsq, and Gs12 all ef-
fectively restored potent activation of adenylate cyclase in re-
sponse to D1R activation in cells lacking endogenous Gαs
subunits (Fig. 4A and SI Appendix, Fig. S8), whereas our assays
did not detect signals mediated by wild-type Gi1, Gq, or G12 in
these cells (SI Appendix, Fig. S9). Likewise, we found that wild-
type Gq, Gqi, Gqs, and Gq12 all fully restored calcium release
from intracellular stores in response to M3R activation in cells
lacking endogenous Gαq subunits (Fig. 4B and SI Appendix, Fig.
S8), whereas our assays did not detect signals mediated by wild-
type Gs, Gi1, or G12 in these cells (SI Appendix, Fig. S9). Notably,
both D1R and M3R coupled significantly to Gi1 heterotrimers in
our direct BRET assay, with ΔBRETmax values that were ap-
proximately half that of the respective cognate heterotrimers
(Fig. 2) but failed to inhibit cAMP accumulation through Gi1 (SI
Appendix, Fig. S9). This suggests that receptors may couple to
heterotrimers, as defined by formation of an agonist- and
nucleotide-sensitive complex, and yet fail to activate a given
signaling pathway even when overexpressed. In contrast to what
we observed with D1R and M3R, G protein chimeras with non-
cognate C termini only partially restored calcium release from
intracellular stores in response to H1R activation. The rank or-
der of restoration by chimeras was Gqi > Gqs > Gq12 (Fig. 4C),
which was consistent with the rank order of H1R coupling to
wild-type Gα subunits (Fig. 1). These results confirm that some
GPCRs can efficiently couple to and activate heterotrimers with
a variety of noncognate Gα C termini. Taken together with our
direct coupling BRET results, these findings indicate a highly
variable influence of the Gα subunit C terminus on coupling
selectivity for different GPCRs.
Discussion
In this study, we used energy transfer between GPCRs and
heterotrimeric G proteins to monitor allosteric coupling between
agonist and nucleotide binding. This approach allowed us to
directly compare coupling of several receptors to multiple G
protein families without relying on downstream signals such as
second messenger production. The use of G protein-deficient
cell lines restricted coupling to defined wild-type and chimeric
Gα subunits, and permeabilization allowed us to control occu-
pancy of both agonist and nucleotide binding sites.
Our results revealed that many receptors couple more pro-
miscuously than expected. For example, every GPCR that we
tested coupled to Gi1 to some extent, and every Gs-coupled re-
ceptor that we tested also coupled somewhat to Gq. As a general
rule, it appears that receptors that couple primarily to Gi het-
erotrimers are more selective than receptors that couple pri-
marily to Gs and Gq heterotrimers. These trends are not readily
apparent in annotated databases of coupling selectivity (3, 4).
We suspect that the sensitivity of our assay, which detects stable
complexes between agonist-occupied receptors and nucleotide-
free G proteins, allowed us to detect secondary coupling (par-
ticularly to Gi1) that might easily be overlooked in functional
studies. Indeed, our results with D1R and M3R coupling to Gi1
suggest that this method can detect interactions that are too
inefficient to lead to physiologically significant G protein acti-
vation in cells. However, it is also possible that weak secondary
coupling interactions have physiological significance under cer-
tain circumstances, as previously demonstrated for β2AR ac-
tivation of Gi heterotrimers (38, 39). We also suspect that a
single assay that reports coupling to G proteins directly from
all four families is likely to produce a more accurate profile of
subtype selectivity than comparison across families with mul-
tiple assays based on second messenger accumulation and/or gene
expression.
Our results with wild-type Gα subunits are consistent with
recent computational and structural studies, which have sug-
gested that the outward displacement of transmembrane domain
6 (TM6) is restricted in active Gi-coupled receptors (8, 10–12, 40,
41). This produces a relatively small pocket in the cytoplasmic
surface of the receptor that can only accommodate the relatively
small C termini of Gi/o family Gα subunits. This mechanism
predicts stringent rejection of Gs and Gq heterotrimers by Gi-
coupled receptors, but no similar barrier to promiscuous Gi ac-
tivation, as we observed. However, our results with Gα chimeras
also show that some Gi-coupled receptors (e.g., α2AR and A1R)
can tolerate noncognate C termini to some extent and, therefore,
suggest that the Gαi core region also partly determines selectivity
for these receptors.
Overall our results support the well-established role of the Gα
subunit C terminus as a key determinant of receptor-G protein
coupling selectivity. However, our findings also emphasize that
other selectivity determinants exist that are equally important or
more important for G protein recognition by many receptors.
This is consistent with several previous reports of selectivity
determinants that lie outside of the distal C terminus (22–25)
and suggests that recognition of several spatially distributed re-
gions of Gα subunits is likely to be a general property of GPCRs.
Remarkably, a few receptors virtually ignored the distal C ter-
minus for the purposes of coupling selectivity. This demonstrates
that the broad functional diversity of GPCRs extends to the
mechanism of receptor-G protein coupling selectivity and
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Fig. 4. Activation of Gα subunit chimeras with noncognate C termini. (A)
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provides direct evidence to support the prediction that different
receptors will recognize different conserved features of a par-
ticular G protein family (5).
Materials and Methods
Materials. Trypsin, Dulbecco's phospate-buffered saline (DPBS), phosphate-
buffered saline (PBS), Hanks' balanced salt solution (HBSS), fetal bovine
serum (FBS), Minimal Essential Medium (MEM), Dulbecco's Modified Eagle
Medium (DMEM), penicillin/streptomycin, and L-glutamine were from GIBCO
(ThermoFisher Scientific). Some receptor ligands, D-luciferin, and forskolin were
purchased from Cayman Chemical. The remaining receptor ligands, digitonin,
apyrase, protease inhibitor, and GDP were purchased from MilliporeSigma. All
detergents were purchased from Anaspec. PEI MAX was purchased from
Polysciences Inc.
Plasmids. Several different GPCR-luciferase constructs were made by
appending either the Renilla luciferase variant Rluc8 or NanoLuc (Nluc) di-
rectly to the receptor C terminus either by QuikChange PCR or by subcloning
into pRluc8-N1 or pNluc-N1 vectors. The V2R-Rluc8 plasmid was received as a
gift from Kevin Pfleger (Harry Perkins Institute of Medical Research,
Nedlands, WA, Australia). In some cases, a short GGSG linker was inserted be-
tween the GPCR and luciferase. Untagged GPCR sequences were obtained
either from the cDNA Resource Center, https://www.cdna.org/home.php?
cat=0 (Bloomsburg University), as a gift from Jonathan Javitch (Columbia
University, New York, NY) or as a gift from Bryan Roth (University of North
Carolina, Chapel Hill, NC; PRESTO-Tango Kit: no. 1000000068, Addgene,
Watertown, MA). Plasmids encoding Gα subunits were purchased from the
cDNA Resource Center. To generate chimeric Gα subunits and Gαs Q227L10delct,
we used the PCR, reverse primers incorporating alternative C-terminal se-
quences, and wild-type Gα templates to amplify full-length Gα subunit se-
quences that were ligated into pcDNA3.1(+) using KpnI and XhoI. To
generate p115RhoGEF-Rluc8, the sequence encoding p115RhoGEF was am-
plified from p115RhoGEF-GFP and ligated into a Rluc8-N1 vector with BglII
and AgeI. All plasmid constructs were verified by Sanger sequencing. A
plasmid encoding the S1 subunit of pertussis toxin (PTX-S1) was kindly
provided by Stephen R. Ikeda (National Institute on Alcohol Abuse and Al-
coholism, Rockville, MD). Plasmids encoding masGRKct-Rluc8, Venus-Kras,
Venus-1–155-Gγ2, and Venus-155–239-Gβ1 have been described previously
(37, 42). The Glosensor-22F cAMP plasmid (E2301) was obtained from
Promega, p115RhoGEF-GFP was received as a gift from Phil Wedegaertner
(Thomas Jefferson College, Philadelphia, PA), and the pT7-CalfluxVTN plas-
mid (43) was a gift from Carl Johnson (Vanderbilt University, Nashville, TN;
Addgene plasmid 83926).
Cell Culture and Transfection.HEK 293 cells (American Type Culture Collection)
were propagated in plastic flasks and on six-well plates according to the
supplier’s protocol. HEK 293 cells with targeted deletion of GNAS and GNAL
(GSKO), HEK 293 cells with additional targeted deletion of GNAS, GNAL,
GNAQ, GNA11, GNA12, and GNA13 that are G protein three family knock-
outs (3GKO), and HEK 293 cells with additional targeted deletions to the
3GKO cells of GNAI1, GNAI2, GNAI3, GNAT1, GNAT2, GNAZ, and GNAO1
that are G protein four family knockouts (4GKO) were derived, authenti-
cated, and propagated as previously described (29, 44). Cells were transiently
transfected in growth medium using linear polyethyleneimine MAX (PEI
MAX; MW 40,000) at an N/P ratio of 20 and were used for experiments 12–48
h later. Up to 3.0 μg of plasmid DNA was transfected in each well of a six-
well plate.
BRET and luminescence assays. Validation of Gα subunit ability to form het-
erotrimers: HEK 293 cells were transiently transfected with masGRKct-Rluc8,
Venus-1–155-Gγ2, Venus-155–239-Gβ1, pcDNA3.1(+), and a Gα subunit in a
(1:1:1:5:0) ratio or a (1:1:1:4:1) ratio or a (1:1:1:0:5) ratio. After a 24-h in-
cubation, cells were washed twice with 1× DPBS, harvested by trituration,
and transferred to opaque black 96-well plates.
Measurement of coupling between receptor and G protein in nucleotide-depleted
cells. 3GKO or 4GKO cells were transiently transfected with a GPCR-Rluc8 and
Gα subunit pair, Venus-1-155-Gγ2, Venus-155-239-Gβ1, and pcDNA3.1(+) or
PTX-S1 in a (1:3:1:1:1) ratio. Experiments with Gαi C termini were conducted
in 4GKO cells for Gαi cognate receptors and in 3GKO cells for all other re-
ceptors. Experiments with Gαi C termini were conducted without PTX-S1, all
other Gα subunits were cotransfected with PTX-S1. After a 48-h incubation,
cells were washed twice with permeabilization buffer (potassium per-
meabilization solution; KPS) containing 140 mM KCl, 10 mM NaCl, 1 mM
MgCl2, 0.1 mM KEGTA, 20 mM NaHEPES (pH 7.2), harvested by trituration,
permeabilized in KPS buffer containing 10 μg·mL−1 high purity digitonin, and
transferred to opaque black 96-well plate. Measurements were made from
permeabilized cells supplemented either with 0.5 mM GDP or 2 U·mL−1 ap-
yrase, in both cases with or without agonist (SI Appendix, Table S1).
Data processing.Net BRET was calculated as the raw BRET ratio minus the same
ratio measured from cells expressing only the BRET donor. Heatmaps rep-
resent ΔBRETmax (Fig. 3; BRET in the presence of agonist and apyrase minus
BRET in the presence of GDP alone), ΔBRETGDP (SI Appendix, Fig. S2; BRET in
the presence of apyrase alone minus BRET in the presence of GDP alone),
and ΔBRETag (SI Appendix, Fig. S3; BRET in the presence of agonist and GDP
minus BRET in the presence of GDP alone). Background ΔBRET (presumably
due to endogenous Gα subunits remaining in 3GKO and 4GKO cells) mea-
sured from control cells not expressing exogenous Gα subunits was routinely
subtracted. Control cells expressed PTX-S1 for experiments with non-Gαi C
termini. Normalized ΔBRET values were obtained by dividing the ΔBRET
observed for each chimera in a heatmap by the highest value observed for
each receptor. For the Glosensor assays with Gs, Gsi, Gsq, and Gs12, vehicle-
subtracted luminescence changes in response to agonist were normalized to
vehicle-subtracted luminescence changes in response to forskolin. For the
Glosensor assay with Gi1 the percent change in luminescence was given as
agonist-induced change in luminescence over baseline luminescence. For the
Calflux assay ΔBRETHA and ΔBRETAch were calculated from the kinetic ex-
periments by subtracting the average of the time points before agonist ad-
dition from the average of the final five time points after agonist addition.
Detailed methods related to second messenger assays, BRET and lumi-
nescence measurements, Gα subunit immunoprecipitation and structural
modeling and molecular dynamics simulations can be found in SI Appendix.
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